The Delhi High Court reiterated that a properly drafted pharmaceutical composition claim cannot be dismissed as a “method of treatment” under Section 3(i), and has sent Medilabo’s neurodegenerative drug application back for a full, merits-based examination.
Read more about Section 3(i) Rejection Set Aside: Court Clarifies Scope of Pharmaceutical Patent ClaimsTag: Delhi High Court
Delhi HC Grants Injunction in Adidas Counterfeit Socks Case
The Delhi High Court granted an ex-parte injunction to Adidas in a trademark infringement and passing-off case concerning counterfeit socks. The Court also appointed a Local Commissioner for seizure and inspection, reinforcing strong protection against IP violations.
Read more about Delhi HC Grants Injunction in Adidas Counterfeit Socks CaseBADAL Trademark Rectification and Assignment Fraud
The Delhi High Court rejected a rectification petition challenging the assignment of the BADAL trademark on grounds of alleged fraud. The Court held that the Petitioner did not submit sufficient evidence to prove fraud or invalidate the registration, upholding the mark’s validity.
Read more about BADAL Trademark Rectification and Assignment FraudPremji Invest Secures Dynamic Injunction against Fraudsters
The Delhi High Court granted Premji Invest a dynamic injunction to counteract ongoing impersonation and intellectual property fraud. The order allows real-time blocking of deceptive websites and apps, ensuring robust protection for both the business and the public.
Read more about Premji Invest Secures Dynamic Injunction against FraudstersDispute Over a Flower: Goodwill in Relevant Trade
The Delhi High Court clarified that prior trademark use is insufficient without proven goodwill in relevant trade or market. The decision in Suparshva Swabs v AGN International highlights the importance of market-specific reputation for passing off claims and sets clear boundaries for allied goods in trademark disputes.
Read more about Dispute Over a Flower: Goodwill in Relevant TradeFMC Corporation’s Plea to Block Natco’s Cyantraniliprole Insecticide Formulation Denied
Delhi High Court refused FMC’s interim plea on a Cyantraniliprole intermediate, citing credible invalidity under Sections 64(1)(a) and 64(1)(e) and a tenable Gillette defence. With expiry close, damages suffice rather than an injunction.
Read more about FMC Corporation’s Plea to Block Natco’s Cyantraniliprole Insecticide Formulation DeniedCourt Clarifies Rules on Confidentiality Clubs and Comparable Licenses in SEP Patent Disputes: Nokia v. Asustek & Ors (2025)
Delhi Hight Court clarifies SEP rules on Confidentiality Clubs and license redactions in Nokia v. Asustek, allowing in-house access without restrictions.
Read more about Court Clarifies Rules on Confidentiality Clubs and Comparable Licenses in SEP Patent Disputes: Nokia v. Asustek & Ors (2025)Court Allows EMD Millipore’s IR Spectroscopy Patent, Clarifies Scope of Sections 3(i) and 59
Delhi HC green-lights EMD Millipore’s IR spectroscopy patent and narrows the sweep of Section 3(i), while affirming compliant claim amendments under Section 59.
Read more about Court Allows EMD Millipore’s IR Spectroscopy Patent, Clarifies Scope of Sections 3(i) and 59Frimline v. K-SMATCO: Delhi HC Rules Firmly in Pharmaceutical Patent Infringement Case
In Frimline v. K-SMATCO, Delhi HC granted interim relief over patent IN 382949, citing strong prima facie infringement of Frimline’s pharmaceutical formulation.
Read more about Frimline v. K-SMATCO: Delhi HC Rules Firmly in Pharmaceutical Patent Infringement CasePromodome Trademark Dispute: Ex-Parte Injunction Granted
The Delhi High Court granted an ex-parte injunction in favour of Promodome Communication Private Limited, restraining the defendant from using identical marks and domain names. The decision highlights the Court’s handling of clear-cut trademark infringement and passing off matters.
Read more about Promodome Trademark Dispute: Ex-Parte Injunction Granted